89BIO (ETNB)
(Delayed Data from NSDQ)
$9.20 USD
+0.11 (1.21%)
Updated May 15, 2024 04:00 PM ET
After-Market: $9.18 -0.02 (-0.22%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth F Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/14/2024
Time: -- |
6/2024 | $-0.55 | -5.45% |
Earnings Summary
For their last quarter, 89BIO (ETNB) reported earnings of -$0.54 per share, missing the Zacks Consensus Estimate of -$0.48 per share. This reflects a negative earnings surprise of 12.50%. Look out for ETNB's next earnings release expected on August 14, 2024. For the next earning release, we expect the company to report earnings of -$0.55 per share, reflecting a year-over-year decrease of 5.77%.
Earnings History
Price & Consensus
Zacks News for ETNB
Novo Nordisk (NVO) Down Despite Kidney Outcomes Study Success
ETNB: What are Zacks experts saying now?
Zacks Private Portfolio Services